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Abstract
The discovery that somatic cells are reprogrammable to pluripotency by ectopic expression of a small subset of
transcription factors has created great potential for the development of broadly applicable stem-cell-based therapies. One
of the concerns regarding the safe use of induced pluripotent stem cells (iPSCs) in therapeutic applications is loss of
genomic integrity, a hallmark of various human conditions and diseases, including cancer. Structural chromosome defects
such as short telomeres and double-strand breaks are known to limit reprogramming of somatic cells into iPSCs, but
whether defects that cause whole-chromosome instability (W-CIN) preclude reprogramming is unknown. Here we
demonstrate, using aneuploidy-prone mouse embryonic fibroblasts (MEFs) in which chromosome missegregation is driven
by BubR1 or RanBP2 insufficiency, that W-CIN is not a barrier to reprogramming. Unexpectedly, the two W-CIN defects had
contrasting effects on iPSC genomic integrity, with BubR1 hypomorphic MEFs almost exclusively yielding aneuploid iPSC
clones and RanBP2 hypomorphic MEFs karyotypically normal iPSC clones. Moreover, BubR1-insufficient iPSC clones were
karyotypically unstable, whereas RanBP2-insufficient iPSC clones were rather stable. These findings suggest that aneuploid
cells can be selected for or against during reprogramming depending on the W-CIN gene defect and present the novel
concept that somatic cell W-CIN can be concealed in the pluripotent state. Thus, karyotypic analysis of somatic cells of origin
in addition to iPSC lines is necessary for safe application of reprogramming technology.
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Introduction
The potential to restore pluripotency to mature somatic cells has
generated new prospects in the establishment of patient-specific
regenerative therapies and has also offered new options for more
advanced and specific modeling of human disease [1,2]. However,
several obstacles remain prior to the therapeutic application of
iPSCs, including the risk of introducing loss of genomic integrity
[3,4]. Recent studies revealed that somatic cell reprogramming
introduces changes at the nucleotide level. Both cell culture length
and conditions were identified as key determinants of this type of
genetic variation [5,6]. In contrast to changes at the nucleotide
level, reprogramming seems to be less permissive to certain types
of structural chromosome damage, such as short telomeres and
double strand DNA breaks [7]. Cells with these kinds of
aberrations are thought to be eliminated during the early stages
of reprogramming by induction of p53-dependent apoptosis [7].
Reprogrammed cells have successfully been generated from
somatic cells that undergo stable inheritance of an abnormal
number of chromosomes, such as Down syndrome. This implies
that aneuploidy (an abnormal number of chromosomes) is not a
barrier to reprogramming [8]. However, the extent to which
defects that promote the continuous reshuffling of whole
chromosomes during mitosis, a condition referred to as whole
chromosome instability (W-CIN) [9], interfere with efficient
reprogramming of somatic cells is unknown.
The molecular mechanisms that underlie chromosome segre-
gation and that safeguard the process are highly complex and
remain incompletely understood [10,11]. In budding yeast, over
one hundred genes are known to cause chromosomal instability
when defective, including genes implicated in chromosome
condensation, sister chromatid cohesion and decatenation, kinet-
ochore assembly and function, spindle formation, mitotic check-
point control and attachment error correction [12,13]. Many
more genes are expected to contribute to chromosomal stability in
mammals, although only a limited number have been identified to
date [9,14]. To begin to address the impact of numerical
chromosome instability, we examined the impact of two distinct
W-CIN gene defects on somatic cell reprogramming. The first
defect involves the BubR1 gene, which encodes a core component
of the mitotic checkpoint, an intricate surveillance mechanism that
acts to delay anaphase onset until all duplicated chromosomes are
properly attached to spindle microtubules and aligned in the
metaphase plate [15–18]. The role of BubR1 in the mitotic
checkpoint is to bind to and inhibit Cdc20, a key activator of the
anaphase-promoting complex/cyclosome (APC/C) that drives
cells into anaphase by targeting cyclin B1 and securin for
degradation by the proteasome [19,20]. In addition, BubR1
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functions at kinetochores to stabilize microtubule-chromosome
attachments [20,21]. While complete loss of BubR1 results in cell
death by mitotic catastrophe, cells with low amounts of BubR1 are
viable despite frequent chromosome missegregation and develop-
ment of near-diploid aneuploidies [22].
The second defect involves the RanBP2 gene, which encodes a
giant nuclear pore complex (NPC) protein with SUMO E3 ligase
activity [23]. At the onset of mitosis, when the nuclear envelope
disintegrates and NPCs disassemble, RanBP2 becomes an
important regulator of topoisomerase II alpha (hereafter referred
to as Top2a), an enzyme that decatenates the centromeric DNA
regions of duplicated chromosomes [24]. Accumulation of Top2a
at mitotic centromeres is dependent on sumoylation by RanBP2.
Complete inactivation of RanBP2 gene expression results in cell
death, but cells with low levels of RanBP2 survive and proliferate
normally despite incomplete DNA decatenation, frequent chro-
mosome missegregation and aneuploidization [24].
Here, we show that both W-CIN gene defects are compatible
with reprogramming. Unexpectedly, however, the two genetic
defects had contrasting effects on the genomic integrity of the
reprogrammed cells, with RanBP2-insufficient MEFs generating
karyotypically normal and chromosomally stable iPSCs and
BubR1-insufficient MEFs almost exclusively yielding aneuploid
and chromosomally unstable iPSC clones. These data indicate that
aneuploid cells can be selected for or against during reprogram-
ming depending on the genetic defect driving the chromosome
number instability. Furthermore, our data reveal that W-CIN that
exists at the somatic cell level can become dormant upon
reprogramming, indicating that testing of both iPSCs and the
iPSC-founding cells for chromosome number instability will be
necessary for the safe application of iPSC technology in
regenerative medicine.
Results
W-CIN Is Not a Barrier for Cellular Reprogramming
We investigated the impact of W-CIN on cell reprogramming
using MEFs derived from BubR1 (BubR1H/H) and RanBP2
hypomorphic (RanBP2–/H) mutant mice [22,24]. Earlier work
demonstrated that BubR1H/H MEFs generate ,10% of normal
BubR1 protein levels and RanBP2–/H mice ,26% of normal
RanBP2 protein levels. We selected BubR1H/H and RanBP2–/H
MEFs for our studies because their aneuploidy rates are quite
similar, with BubR1H/H cultures having 36% aneuploid cells at
passage 5 (P5) [25] and RanBP2–/H cultures 33% [24]. Moreover,
entirely different mechanisms drive aneuploidization in BubR1H/H
and RanBP2–/H MEFs. Newly performed chromosome counts on
P5 wildtype, BubR1H/H and RanBP2–/H MEFs confirmed our
previously published aneuploidy rates for these genotypes
(Table 1). To induce reprogramming to pluripotency, Oct-3/4,
Sox2, and Klf4 expression constructs were introduced in P5
wildtype, BubR1H/H, and RanBP2–/H MEFs by retroviral trans-
duction. c-Myc was omitted because its overexpression has been
associated with aneuploidization [26]. Embryonic stem (ES) cell-
like colonies emerged around two weeks after transduction,
irrespective of genotype. The number of ES cell-like colonies
emerging from BubR1H/H or RanBP2–/H MEF lines were similar to
those originating from wildtype MEFs (Figure 1A). The finding
that ES-like colonies developed from BubR1H/H MEFs with
normal efficiency was somewhat unexpected because p19Arf,
p16Ink4a and p53 are elevated in P5 BubR1H/H MEFs [25,27] and
have previously been shown to impair reprogramming [7,28]. We
found that growth rates of P5 BubR1H/H MEFs were similar to
those of P5 wildtype and RanBP2–/H MEFs (Figure S1), implying
that the level of p19Arf, p16Ink4a and p53 engagement was too low
to have a substantial impact on global cell cycle progression.
Individual ES cell-like colonies were picked and clonally
expanded on monolayers of mitotically inactivated STO feeder
cells that exogenously express NEO and leukemia inhibitory factor
(LIF), referred to as SNL feeders [29]. The morphology and
growth rate of these cells was similar to that of murine ES cells
(ESCs) derived from 129Sv/E6C57BL/6 blastocysts, irrespective
of genotype (Figure 1B and 1C). We used immunofluorescence to
screen for the presence of ES cell-associated markers. Repro-
grammed cells derived from all three MEF genotypes consistently
expressed Oct3/4, Nanog, and SSEA1, with each marker
exhibiting the proper fluorescence intensity and subcellular
localization (Figure 1D). RT-PCR analysis confirmed that Oct4
and Nanog expression was elevated, together with several other ES
cell-associated marker genes (Figure 1E). Consistent with repro-
gramming [30,31], retroviral expression of Yamanaka factors was
silenced in iPSCs of all three genotypes (Figure 1E). Furthermore,
the puromycin resistance gene, which is co-expressed with
exogenous Oct-3/4, Sox2, and Klf4 from an IRES [1], was co-
silenced upon reprogramming as evidenced by prompt iPSC death
in the presence of puromycin (Figure 1F).
To further evaluate whether BubR1H/H and RanBP2–/H iPSC
clones were properly reprogrammed, we tested their developmen-
tal potential by several methods. First, we formed embryoid bodies
(EBs) by growing wildtype, BubR1H/H and RanBP2–/H iPSC clones
in suspension in ES medium lacking LIF (Figure 2A). EBs
harvested at day 5 and 10 expressed ectodermal (Pax3 and Mash1),
mesodermal (Tbx5 and Brachyury), and endodermal (AFP and
Foxa2) markers irrespective of genotype [32] (Figure 2B–2D),
indicating that all three germ layers were present. Second, when
injected subcutaneously into SCID mice, wildtype (n = 3),
BubR1H/H (n= 6) and RanBP2–/H iPSC clones (n = 5) produced
aggressively growing teratomas that contained tissue structures
representing all three embryonic germ layers (Figure 3A and 3B).
Third, when injected into blastocysts, wildtype (n = 3), BubR1H/H
(n= 3), and RanBP2–/H iPSC clones (n = 3) produced viable
chimeric animals, with the exception of one RanBP2–/H iPSC
Author Summary
iPSC technology has the potential to revolutionize stem-
cell based regenerative medicine and would also allow for
the production of patient-specific cells for disease model-
ing and drug discovery. One of the primary safety concerns
of iPSCs is genetic instability, which is associated with
cancer and various other diseases and includes abnormal-
ities in both chromosomal structure and number. Whereas
certain structural chromosome changes have been shown
to preclude somatic cell reprogramming, the effect of
whole-chromosome reshuffling on this process is com-
pletely unknown. Here we show that BubR1 and RanBP2
hypomorphic MEF lines, which are highly prone to
erroneous chromosome segregation due to mitotic
checkpoint and DNA decatenation failure, respectively,
reprogram to pluripotency with normal efficiency. How-
ever, while RanBP2 hypomorphic MEFs yielded karyotyp-
ically normal iPSC clones with generally low chromosomal
instability rates, BubR1 hypomorphic MEFs almost exclu-
sively yielded aneuploid iPSC clones with high instability
rates. These data provide important new insights into the
genomic integrity requirements during somatic cell repro-
gramming, and they establish that the safe application of
iPSC technology requires screening of both iPSCs and the
iPSC-founder cells for chromosome number instability.
Reprogramming Permits Whole-Chromosome Instability
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clone (Figure 3C). Failure to generate chimeras by this RanBP2–/H
iPSC clone was most likely due to the low number of pups born
rather than lack of pluripotency as it was capable of forming
teratomas in which cell types derived from the three germ layers
were detectable. Collectively, the above data suggest that MEFs
with W-CIN gene defects fully reprogram to iPSCs with similar
efficiency as wildtype MEFs.
Reprogramming Ability of Aneuploid Cells Is W-CIN
Gene–Dependent
Next, we performed chromosome counts on metaphase spreads
of independent RanBP2–/H and BubR1H/H iPSC clones to
determine whether there might be a bias against reprogramming
of aneuploid MEF cells and to compare W-CIN rates before and
after reprogramming. As shown in Table 2, all ten RanBP2–/H
Figure 1. MEFs with W-CIN gene mutations can be efficiently reprogrammed into iPSCs. (A) Average numbers of ES cell-like colonies
derived from MEFs with indicated genotypes (n = 3 independent MEF lines). Error bars represent SEM. (B) Light microscopy images of iPSC colonies
with indicated genotypes growing on SNL feeder layer. Scale bar represents 500 mm. (C) Growth curves of mESCs and iPSC clones derived from MEFs
of the indicated genotypes. We note that there were no significant differences in growth between individual iPSC lines of each genotype. Error bars
represent SD. (D) Immunostaining of wildtype, RanBP2–/H and BubR1H/H iPSC for ES cell markers. Representative images are shown. DNA of cells
stained for Oct3/4 and Nanog was visualized with Hoechst. Scale bar represents 200 mm. (E) RT-PCR analysis of retroviral transgene silencing and
endogenous pluripotency-associated gene induction. (F) Silencing of retroviral expression after direct reprogramming. BubR1H/H iPSCs die upon
addition of 4 mg/ml puromycin for 24 h. Scale bar represents 500 mm.
doi:10.1371/journal.pgen.1002913.g001
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iPSC clones examined predominantly consisted of cells with 40
chromosomes, indicating that they originated from karyotypically
normal MEF cells. In contrast, only one of 11 BubR1H/H iPSC
clones analyzed predominantly consisted of cells with 40
chromosomes, implying that 10 clones originated from aneuploid
BubR1H/H MEFs (Table 2). However, an alternative explanation
for the data would be that reprogramming is restricted to
karyotypically normal BubR1H/H MEFs but that massive aneu-
ploidization initiated after the completion of reprogramming
accounts for the genesis of iPSC clones where the predominant
population of cells has a chromosome number other than 40 (see
Figure S2). To explore the probability of this model, we selected
three independent BubR1H/H iPSC clones listed in Table 2 (each
having a majority population of cells with a different chromosome
number), prepared subclones from single cells and analyzed their
karyotypes. As shown in Table 3, in each instance, the majority of
the subclones maintained a karyotype that closely resembled that
of the parental line. Specifically, in most subclones the majority of
the cells had a chromosome number found in the majority cells of
the corresponding parental clone. These data argue against the
notion that severe aneuploidization at the early stages of clonal
expansion of reprogrammed cells accounts for prevalence of
aneuploid BubR1H/H iPSC clones, and are consistent with the idea
that aneuploid BubR1H/H MEFs reprogram more efficiently than
BubR1H/H MEFs with a normal karyotype. Wildtype MEFs, which
typically have aneuploidy rates of ,9% at P5 [22,24], showed a
moderate bias for reprogramming of aneuploid MEFs, with 23%
of iPSC clones analyzed originating from aneuploid MEF cells.
Thus, perhaps biased reprogramming of karyotypically abnormal
MEFs may not be restricted to BubR1H/H cells.
RanBP2–/H iPSC clones on average had a much lower
percentage of aneuploid cells (12%67%; Table 2) than
RanBP2–/H MEFs (33%62%; Table 1). This reveals that RanBP2
insufficiency has a differential impact on the accuracy of
chromosome segregation in pluripotent and differentiated cells,
indicating that certain W-CIN gene defects can be masked during
reprogramming. Redifferentiation of RanBP2–/H iPSC clones with
low rates of aneuploidy resulted in a dramatic increase in
aneuploidization (Figure 4A and 4B). In contrast, redifferentiation
of wildtype iPSC clones resulted only in very modest increases in
aneuploidy. These data argue against the possibility that
reprogramming of RanBP2–/H MEFs select for compensatory
genetic alterations that improve chromosome segregation fidelity
and further support the notion that chromosomal instability
associated with RanBP2 hypomorphism is masked at the
pluripotent state.
Reprogramming Reduces Dependence of Sister
Centromere Decatenation on RanBP2
Decatenation of centromeric DNA by Top2a is essential for
proper chromosome separation of sister chromatids [33]. Previ-
ously, we showed that targeting of Top2a to inner centromeres of
mitotic chromosomes is regulated by RanBP2-mediated sumoyla-
tion [24]. Based on these earlier findings, we proposed that the
marked decrease in aneuploidization upon reprogramming of
RanBP2–/H MEFs might be due to improved centromeric targeting
of Top2a. To explore this hypothesis, iPSC clones derived from
wildtype and RanBP2–/H MEFs were stained with antibodies
against Top2a and centromeres. As expected, nearly all wildtype
iPSCs accumulated Top2a to the inner centromeres at mitosis
onset (Figure 5A and 5B). Consistent with correction of W-CIN
upon reprogramming, RanBP2–/H iPSCs localized Top2a to the
inner centromeres with similar efficiency as iPSC derived from
wildtype MEFs [24].
It has been reported that a significant number of proteins
implicated in cell cycle regulation are upregulated in pluripotent
stem cells, including RanBP2 [34], which led us to speculate that
normalization of Top2a localization in RanBP2–/H iPSC cells
might be due to loss of RanBP2 hypomorphism during
reprogramming. To test this, we used western blot analysis to
compare RanBP2 protein levels in iPSCs derived from wildtype
and RanBP2–/H iPSC clones. We observed that RanBP2 levels
were indeed reduced in RanBP2–/H iPSCs (Figure 5C and Figure
S3) and that the level of reduction was similar to that documented
for RanBP2–/H MEFs [24]. Furthermore, Top2a levels were
normal in RanBP2–/H iPSCs, indicating that the mechanism of
correction of Top2a localization to inner centromeres does not
involve compensatory expression (Figure 5C). Furthermore, it has
been proposed that p53 safeguards against aneuploidy [35,36],
which led us to speculate that RanBP2 insufficiency might sensitize
reprogrammed cells to aneuploidy-induced p53 induction, thereby
allowing for more efficient elimination of aneuploid iPSCs from
RanBP2–/H iPSC cultures. We explored this potential mechanism
by measuring p53 levels in extracts prepared from RanBP2–/H and
Table 1. MEF aneuploidy rates prior to reprogramming.
MEF
genotype Line
Mitotic
cells
inspected
Percent
aneuploid
cells Karyotypes with the indicated chromosome number
35 36 37 38 39 40 41 42 43 44
Wildtype 1 50 12 1 1 1 1 44 2
2 50 10 1 2 45 2
3 50 8 1 46 2 1
BubR1H/H 1 50 38 1 3 1 5 31 1 4 3 1
2 50 40 3 2 3 3 30 3 4 1 1
3 50 36 4 3 1 2 32 4 2 2
RanBP2–/H 1 50 30 2 2 1 35 6 1 3
2 50 34 2 2 7 33 5 1
3 50 34 2 1 2 5 33 2 3 2
Chromosome counts were performed at P5.
doi:10.1371/journal.pgen.1002913.t001
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WT iPSC cultures, but no detectable differences in p53 levels were
observed between the two genotypes (Figure 5D). Taken together,
the above data indicate that pluripotent cells are less dependent on
RanBP2 for proper Top2a targeting to inner centromeres than
somatic cells.
Subcloning of iPSCs Can Improve Chromosome Number
Integrity
Our finding that cultures of wildtype iPSCs originating from
karyotypically normal MEF cells have aneuploidy rates of 12–36%
highlights that reprogramming is subject to substantial cell culture
induced aneuploidy (Table 2). High rates of chromosomal
instability pose a potential safety risk in regenerative therapies
based on iPSCs, since aneuploidization is potentially tumor
promoting [9,10,37]. Furthermore, because aneuploidy can alter
the metabolic and proliferative properties of cells [4,38,39],
aneuploidization of cultured iPSCs may impact the analysis of
studies using disease-specific iPSCs derived from patients. It is
Figure 2. iPSCs from W-CIN mutant MEFs differentiate into EBs
comprising of all embryonic germ layers. (A) Representative EBs
derived from mESCs and iPSC clones. (B–D) qRT-PCR analysis of EBs
derived from mESCs and iPSC clones for expression of the indicated
embryonic germ layer markers. Error bars represent SEM.
doi:10.1371/journal.pgen.1002913.g002
Figure 3. iPSCs derived from W-CIN MEFs form teratomas and
chimeric mice. (A) Analysis of teratomas derived from iPSC clones of
the indicated genotypes. mESCs were used as a control for teratoma
formation. (Top) Images of representative teratomas collected 21 days
after injection of iPSCs into SCID mice. (Bottom) Teratoma volume
plotted as a scatter plot with mean. We note that RanBP2–/H and
BubR1H/H MEFs failed to form teratomas. (B) Hematoxylin and eosin
staining of teratoma sections. Scale bar is 200 mm. (C) Aneuploid iPSCs
injected into BALB/c host blastocysts produce viable chimeric mice.
(Left) Summary of blastocyst injection results. Clone ID#s correspond to
iPSC clones listed in Table 2. Numbers in parenthesis indicate total
number of pups delivered. (Right) Images of chimeric animals produced
by blastocyst injection of iPSCs. The ages of the pups are indicated in
days.
doi:10.1371/journal.pgen.1002913.g003
Reprogramming Permits Whole-Chromosome Instability
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therefore important to identify methods for selection of pluripotent
cells with normal karyotypes and for maintenance of karyotypic
stability during cell culture. To test if aneuploidy rates of wildtype
iPSC clones can be decreased through subcloning, we generated
subclones from three independent wildtype iPSC cultures (clone
ID# 1, 2 and 3 in Table 2), which had aneuploidy rates of 12%,
12% and 14%, respectively. Subclones of each of these iPSC
clones were expanded and subjected to chromosome counts (at P3
after picking). Although none of the subclones analyzed consisted
of cells with only 40 chromosomes (Table 4), 8 out of 19 subclones
had at least two fold reduced aneuploidy rates compared to their
parental iPSC clones, with 2 subclones containing 2% aneuploidy
and four subclones containing 4% aneuploidy. Only three of the
subclones had substantially higher aneuploidy rates. When re-
examined after 6 additional passages, 3 of 4 subclones with an
improved karyotype showed persistence of the upgrade (Table 4).
Thus, although subcloning could not entirely eliminate aneuploi-
dy, it yielded several iPSC cultures with continued low rates of
karyotypic instability.
Discussion
Although the importance of iPSC technology for regenerative
therapies is broadly recognized, several hurdles to their clinical use
Table 2. W-CIN gene defects do not preclude somatic cell reprogramming.
iPSC
genotype
iPSC
clone
ID#
Mitotic
cells
inspected
Percent
aneuploid
cells
Percent
deviation Karyotypes with the indicated chromosome number
35 36 37 38 39 40 41 42 43 44 45
RanBP2–/H 1 50 4 4 1 1 48
2 50 6 6 2 47 1
3 50 8 8 1 2 46 1
4 50 8 8 1 1 46 1 1
5 50 10 10 2 45 3
6 50 10 10 4 45 1
7 50 12 12 1 1 2 44 2
8 50 16 16 2 1 2 42 2 1
9 50 18 18 1 5 41 3
10 50 28 28 1 3 1 7 36 2
BubR1H/H 1 100 53 53 1 3 2 7 19 47 20 1
2 50 76 42 1 1 12 29 6 1
3 50 90 48 1 5 26 16 2
4 50 78 76 1 2 2 11 12 8 10 3 1
5 50 92 46 1 1 1 1 4 3 27 11 1
6 50 96 58 1 1 2 2 17 21 5 1
7 50 82 66 4 1 1 9 13 17 5
8 50 94 60 3 9 20 11 5 2
9 50 98 60 1 2 1 4 15 20 3 4
10 50 96 68 1 2 1 2 8 12 16 7 1
11 50 98 48 1 2 1 1 4 4 8 26 3
Wildtype 1 50 12 12 1 1 2 44 1 1
2 50 12 12 1 3 44 2
3 50 14 14 1 3 43 3
4 50 16 16 1 1 4 42 1 1
5 50 18 18 1 1 41 7
6 50 20 20 2 2 5 40 1
7 50 20 20 1 2 6 40 1
8 50 28 28 1 1 4 4 36 4
9 50 34 34 1 33 15 1
10 50 36 36 1 1 1 2 7 32 3 1 2
11 50 90 16 2 42 5 1
12 50 92 18 1 1 1 4 41 2
13 50 98 16 1 1 3 42 2 1
Chromosome counts on iPSC clones with indicated genotypes. Percent deviation indicates the fraction of spreads with the chromosome number different from the
most frequent count.
doi:10.1371/journal.pgen.1002913.t002
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exist, including the potential of genomic instability. Here we have
examined the relationship between somatic cell reprogramming and
W-CIN, a type of genomic instability associated with cancer and
other human disorders. Our studies provide several important new
insights that should improve the efficacy of iPSC use in future
clinical applications. First, we demonstrate that W-CIN does not
pose a barrier to reprogramming. Second, we show that W-CIN
iPSCs are capable of differentiating into all three distinct germ layer
cell types. Third, we show that although MEFs with two distinct W-
CIN defects efficiently reprogram into iPSCs, they do so with highly
contrasting outcomes on chromosome number integrity and
stability (Figure 6): our data suggest that BubR1 hypomorphic
iPSC clones preferentially originate from aneuploid MEFs, while
RanBP2 hypomorphic iPSC clones preferentially stem from MEFs
with normal diploid chromosome numbers. Fourth, our data
uncovered the fascinating concept that a W-CIN gene defect
responsible for severe aneuploidization in somatic cells can become
dormant upon reprogramming. The particular W-CIN defect that
revealed this concept is RanBP2 hypomorphism. We ruled out that
a failure to maintain the RanBP2 hypomorphic status after
reprogramming is responsible for restoring high-fidelity chromo-
some segregation. One possibility is that SUMO E3 ligases other
than RanBP2, such as PIAS proteins, redundantly targeting Top2a
to inner centromeric regions of duplicated chromosomes [40–42].
An alternative explanation might be that Top2a accumulates to
inner centromeres in a SUMO independent fashion in pluripotent
Table 3. Karyotypes of subcloned BubR1 hypomorphic iPSCs reflect the parental kayotype profile.
Parental
BubR1H/H
iPSC clone
iPSC
ID#
Mitotic
cells
inspected
Percent
aneuploid
cells
Percent
deviation Karyotypes with the indicated chromosome number
35 36 37 38 39 40 41 42 43 44 45
Clone 1 Parental 100 53 53 1 3 2 7 19 47 20 1
Subclone 1 50 46 46 1 1 2 9 27 7 3
Subclone 2 50 44 44 2 1 1 4 6 28 6 1 1
Subclone 3 50 44 44 2 1 28 17 2
Subclone 4 50 40 40 5 5 5 30 4 1
Subclone 5 50 40 40 1 2 10 30 7
Subclone 6 50 34 34 2 2 8 33 3 2
Subclone 7 50 20 20 2 6 40 2
Subclone 8 50 88 46 3 2 1 2 3 6 27 6
Subclone 9 50 90 40 1 1 5 30 8 5
Subclone 10 50 80 32 1 1 2 10 34 2
Clone 5 Parental 50 92 46 1 1 1 1 4 3 27 11 1
Subclone 1 50 84 64 4 8 17 18 3
Subclone 2 50 100 46 11 27 12
Subclone 3 50 96 46 1 2 14 27 6
Subclone 4 50 96 42 1 1 1 2 5 29 9 2
Subclone 5 50 92 44 1 4 9 28 8
Subclone 6 50 96 40 1 2 2 8 30 6 1
Subclone 7 50 94 56 2 1 1 3 4 8 22 6 3
Subclone 8 50 98 52 1 1 2 9 24 13
Subclone 9 50 100 50 1 12 12 25
Subclone 10 50 100 36 1 14 32 3
Clone 11 Parental 50 98 48 1 2 1 1 4 4 8 26 3
Subclone 1 50 90 58 1 5 2 3 15 21 3
Subclone 2 50 96 46 1 1 2 5 3 11 27
Subclone 3 50 96 44 1 1 2 3 5 8 28 2
Subclone 4 50 98 50 1 2 2 1 5 3 6 25 5
Subclone 5 50 94 56 1 1 1 3 5 8 3 22 6
Subclone 6 50 98 46 1 1 1 1 1 6 27 11 1
Subclone 7 50 98 52 1 2 1 1 5 24 14 1 1
Subclone 8 50 100 34 2 2 8 33 4 1
Subclone 9 50 96 32 1 1 2 8 34 2 2
Subclone 10 50 94 56 1 1 3 1 1 5 16 22
Parental IPSC clone ID#s correspond to clones listed in Table 2. The most frequent count of each iPSC subclone is in bold typeface. Percent deviation indicates the
fraction of spreads with the chromosome number different from the most frequent count.
doi:10.1371/journal.pgen.1002913.t003
Reprogramming Permits Whole-Chromosome Instability
PLOS Genetics | www.plosgenetics.org 7 August 2012 | Volume 8 | Issue 8 | e1002913
cells. Regardless of the precise mechanism by which W-CIN can be
concealed in iPSCs, the phenomenon itself highlights that it will not
only be important to check iPSCs for aneuploidization but also the
somatic cells from which they originated.
The observation that aneuploid cells within BubR1 hypomor-
phic MEF cultures undergo preferential reprogramming is
puzzling given that BubR1 insufficiency engages the p16Ink4a-Rb
and p53-p19Arf pathways [43], both of which have been shown to
inhibit reprogramming [7,28]. Perhaps activation of these tumor
suppressor pathways is necessary but not sufficient for the
elimination of aneuploid MEFs during the early stages of
reprogramming. The observation that BubR1H/H aneuploid MEFs
preferentially dedifferentiate raises the possibility that BubR1
might be a key component of a surveillance pathway that prevents
aneuploid cells from reprogramming. Interestingly, in earlier
studies we have shown that BubR1 levels decrease with aging in
various mouse tissues [22,44,45]. This, together with the
observation that aneuploid MEFs with low amounts of BubR1
readily reprogram into chromosomally unstable iPSCs implies that
reprogramming of somatic cells from elderly individuals into
karyotypically normal and stable iPSCs may be particularly
challenging. It will be interesting to further explore this possibility
by testing whether restoration of high BubR1 levels in somatic cells
of older individuals would improve iPSC quality.
Mitosis is more prone to errors when cells divide in culture as
evidenced by the low rates of chromosome missegregation observed
in early passage MEFs from wildtype mice [26,46]. Although the
actual cause of such aneuploidies is unknown, it is generally believed
that they are induced by cell culture stress [47]. Karyotypically
normal mouse ESC lines used in gene targeting experiments are
known to acquire severe aneuploidy upon extensive in vitro passaging,
indicating that pluripotent cells are also susceptible to cell culture-
induced chromosome segregation errors [48]. Our finding that
aneuploid cells emerge in iPSC cultures originating from karyotyp-
ically normal wildtype MEFs (Table 1) confirms earlier indications
that reprogrammed cell lines, like ESC lines, are subject to cell culture
induced aneuploidization [49]. Since aneuploidy poses a risk for
negative side effects in therapeutic applications, it will be important to
devise strategies to avoid it. We find that aneuploidization rates of
iPSC clones derived from wildtype MEF cultures can be markedly
Figure 4. RanBP2 hypomorphic iPSCs reestablish W-CIN after redifferentiation. (A) Light microscopy images of cell cultures derived from
EBs with indicated genotypes. Scale bar represents 500 mm. (B) Chromosome counts on EB-derived cells paired with the karyotype of the parental
iPSC clone from Table 2.
doi:10.1371/journal.pgen.1002913.g004
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reduced through subcloning, implying that iPSC cultures contain
subsets of cells that are quite resistant to cell culture induced mitotic
stress. Thus subcloning might be a pragmatic method to produce
iPSC lines with high chromosome integrity.
Materials and Methods
Cell Culture
BubR1H/H and RanBP2–/H MEFs were previously established
[22,24]. These MEF lines had a C57BL/66129Sv/E mixed genetic
background. MEFs were grown in DMEM containing 10% FCS,
2 mM L-glutamine, 1 mM sodium pyruvate, 100 mM non-essential
amino acids, 55 mg/ml ß-mercaptoethanol, and 10 mg/ml genta-
mycin. IPSCs were generated and routinely cultured in ES cell
medium. This medium consisted of high-glucose DMEM supple-
mented with 15% FCS, 2 mM L-glutamine, 1 mM sodium
pyruvate, 100 mM non-essential amino acids, 55 mg/ml ß-mercap-
toethanol, 10 mg/ml gentamycin and 500 U/ml ESGRO LIF
(Millipore). SNL cells were obtained from Dr. Allen Bradley
[50,51]. These cells were mitotically inactivated by irradiation (3000
rads) and seeded on plates coated with 0.1% gelatin in PBS. ESCs
used in this study were TL1 cells obtained from Dr. Bridgid Hogan.
These cells were derived from a 129/Sv mouse blastocyst [52].
Generation of iPSCs
IPSCs were generated essentially as described in detail
elsewhere [53]. Briefly, using the pMXs-IP vectors (obtained via
Addgene), retroviruses expressing Oct3/4, Sox2 and Klf4 were
produced from Plat-E cells (Cell Biolabs) using Lipofectamine
2000 (Invitrogen). Supernatants were collected 48 h after trans-
fection, passed through 0.45 mm cellulose filter, and mixed 1:1:1
(v/v). Eight6105 fibroblasts were seeded onto 10-cm culture plates
Figure 5. RanBP2–/H iPSCs efficiently recruit Top2a to the inner centromeres. (A) Immunolocalization of Top2a in prometaphase of wildtype
and RanBP2–/H iPSCs. Centromeres are visualized with ACA antibody. DNA was stained with Hoechst. Scale bar represents 10 mm (20006
magnification) (B) Quantification of prometaphases with inner centromeric versus diffuse localization of Top2a. At least 50 prometaphases were
analyzed per genotype. Error bars represent SD. (C) Western blot analysis of iPSC extracts probed for RanBP2 and Top2a. Actin served as a loading
control. (D) Western blot analysis of iPSC extracts probed for RanBP2 and p53. Actin served as a loading control.
doi:10.1371/journal.pgen.1002913.g005
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and the next day infected with 10 ml of viral cocktail in the
presence of 4 mg/ml polybrene. Seventy-two h post-infection, the
medium was replaced with mouse ES cell medium and refreshed
every 1 to 2 days. Colonies were picked 16–26 days post-
transduction, trypsinized and seeded in 96 wells coated with
irradiated SNL cells. To compare the efficiency of iPSC
generation between wildtype and mutant MEFs, 3 lines of
wildtype, RanBP2–/H and BubR1H/H MEFs were transduced with
the same virus cocktail as described above. The number of ES cell-
like colonies was manually counted after 3 weeks. To subclone
iPSC clones, single cell suspensions were prepared. Two hundred
fifty, 500 and 1,000 iPSCs were seeded on 10-cm dishes with SNL
feeders. IPSC colonies were picked and clonally expanded.
Growth Rate Analyses
Growth curves of MEFs were generated using 3 independent
MEFs lines for each of the indicated genotypes. P4 MEFs were
recovered from frozen stocks. The next day (day 0), 1.56104
MEFs were seeded into 35-mm dishes (in duplicate). Cell counts
were performed 24 h after seeding and at 24-h intervals thereafter,
for up to 4 days. The average number of cells per each time point
was calculated by averaging the average of the duplicates for each
of the 3 independent MEF lines. Log cell numbers were calculated
by dividing the average number of cells counted on each of the
days by the number of cells seeded. To determine the growth rates
of iPSCs, 3 wildtype, 3 BubR1H/H and 3 RanBP2–/H iPSC clones
were seeded in duplicate at 16105 cells per well of a 6-well plate
density. Every 3 days, we trypsinized the cultures, counted the
number of cells, and reseeded 16105 cells. This process was
repeated 9 times. For each iPSC line, the average between
duplicates was calculated. The growth curves for each genotype
were plotted as the average of the three corresponding cell lines.
The cumulative cell numbers are indicated on the Y-axis on a
logarithmic scale.
Testing for Complete Reprogramming to Pluripotency
Retroviral silencing. iPSCs were grown in the presence of
4 mg/ml puromycin. After 24 h, cells were examined for viability
using an inverted microscope.
ES markers (RT–PCR). For ES cell and iPSC clones, feeder
cells were removed from culture by incubating the mixed cell
suspension in gelatin-coated dishes for 30 min. RNA was isolated
from cells using Trizol (Invitrogen). Reverse transcription was
performed using Superscript III and the random hexamer primer
(Invitrogen). PCR was performed using Platinum taq (Invitrogen).
The forward primers for exogenous Oct4, Sox2 and Klf4 and the
primer sets for endogenous Oct4, Sox2, Klf4, Nanog, Rex1, Esg1
and G3pdh were described previously [54]. The reverse primer for
exogenous Oct4, Sox2, and Klf4 was 59-ATATCAAGCTTATC-
GAGCGGC-39.
Table 4. Subcloning can reduce aneuploidy rates of iPSC clones.
Parental
iPS clone
iPSC
ID#
Mitotic
cells
inspected
Percent
aneuploid
cells Karyotypes with the indicated chromosome number
36 37 38 39 40 41 42 43 44
Wildtype 1 Parental 50 12 1 1 2 44 1 1
Subclone 1 50 6 3 47
Subclone 2 50 10 1 45 4
Subclone 3 50 10 3 45 1 1
Subclone 4 50 14 1 43 4 1 1
Subclone 5 50 28 2 1 1 2 36 6 1 1
Wildtype 2 Parental 50 12 1 3 44 2
Subclone 1 50 2 (4) (2) 49 (48) 1
Subclone 2 50 2 (4) (1) 49 (48) 1 (1)
Subclone 3 50 4 (14) (2) (5) 48 (43) 2
Subclone 4 50 4 (2) 1 48 (49) 1 (1)
Subclone 5 50 4 2 48
Subclone 6 50 4 1 1 48
Subclone 7 50 8 1 2 46 1
Subclone 8 50 12 1 44 5
Subclone 9 50 30 1 5 35 9
Wildtype 3 Parental 50 14 1 3 43 3
Subclone 1 50 6 3 47
Subclone 2 50 8 3 46 1
Subclone 3 50 12 1 1 44 3 1
Subclone 4 50 14 4 43 3
Subclone 5 50 92 4 46
Chromosome counts on wildtype iPSC subclones. Parental IPSC clone ID#s correspond to clones listed in Table 2. The subclones that had at least two fold reduced
aneuploidy rates compared to their parental iPSC clones are in italic typeface. Subclone 2-1, 2-2, 2-3, and 2-4 were re-examined after 19 days in culture and the
karyotype is shown in parenthesis.
doi:10.1371/journal.pgen.1002913.t004
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Differentiation markers (qRT–PCR). mESCs or iPSC
clones were differentiated by culturing in suspension at 26106
cells/ml in ES medium without LIF. EBs were collected after 5 and
10 days for RNA isolation. Preparation of cDNA was done as above.
Real-time PCR was performed using SYBR green master mix
(Invitrogen) with 95uC for 5 min, 40 cycles at 95uC for 15 sec, 60uC
for 30 sec, 72uC for 30 sec, followed by a dissociation cycle. Fold
changes in gene expression in EBs (day 5 and day 10) vs. iPSCs (day
0) were calculated based on the 22DDCT method and normalized to
GAPDH. The primers used were described previously [32].
Teratoma formation. iPSCs growing on SNL feeders in one
well of a 6-well plate were trypsinized, washed once with ES
medium, and suspended in ES medium at 46106 cells per ml.
26106 cells were injected into the subcutaneous tissue above the
rear haunch of 5 to 8 week old C.B-17 SCID males (Taconic
#CB17SC-M) using a 23GX1 needle. Twenty one days post
injection, teratomas were dissected, photographed, measured
using a digital caliper (World Precision Instruments, Inc.
#501601), fixed in 10% formalin for 20 h and processed for
paraffin embedding. Sections were prepared and routinely stained
with hematoxylin and eosin and scored for the presence of tissues
derived from all three germ layers as previously described [8]. As
controls we used mESCs (TL1), wildtype and BubR1H/H MEFs,
and ES medium alone. The tumor volume values were plotted
using Prism 4.0a for Mac. Pictures were acquired using an
Olympus AX70 microscope with Olympus DP71 color camera,
UPlanFl 206/0.50 Olympus objective and DP Controller
3.1.1.267 software.
Chimera formation. Wildtype, BubR1H/H and RanBP2–/H
iPSC clones growing on SNL feeders were trypsinized and injected
into BALB/c host blastocysts (Harlan) using standard procedures.
In Vitro Differentiation of iPSCs
Wildtype and RanBP2–/H iPSC cultures were trypsinized,
collected in 8 ml ES cell medium and plated onto a gelatin-
coated 10-cm dish for 1 h to allow SNL feeders to attach. The
supernatant was then collected, pelleted and resuspended in ES
cell medium without LIF. 26106 cells in 10 ml medium were
transferred to a Petri dish to induce EB formation. The medium
was changed every 2 days by collecting the suspension in 15 ml
falcon tube, leaving the cells to settle at the bottom, then replacing
the supernatant with fresh medium. After 8 days, EBs were
collected and seeded onto gelatin-coated 10-cm culture dish for
outgrowth of differentiated cells. Karyotyping was performed 5
days thereafter.
Indirect Immunofluorescence and Western Blotting
For immunofluorescence, iPSCs were seeded on 0.1% gelatin-
coated glass slides. After 24–48 h, the cells were fixed in 4%
paraformaldehyde for 10 min at room temperature, washed 36
with PBS and permeabilized/blocked for 15 min in PBS
containing 0.1% Triton X-100 and 5% FCS. The cells were then
incubated with primary antibodies against OCT3/4 (1:50, mouse
monoclonal, sc-5279, Santa Cruz Biotechnology), NANOG
(1:100, rabbit polyclonal, A300-398A, Bethyl Laboratories Inc.),
and SSEA1 (1:100, mouse monoclonal, Developmental Studies
Figure 6. Model illustrating the contrasting effects of W-CIN gene defects on iPSC genomic integrity. RanBP2 hypomorphic iPSCs
originate from MEFs with normal chromosome numbers and exhibit a high degree of chromosome number stability. BubR1 hypomorphism results in
selective reprogramming of aneuploid cells and yields chromosomally unstable iPSCs. iPSC cultures established from wildtype MEFs typically contain
relatively small subpopulations of cells with abnormal chromosome numbers.
doi:10.1371/journal.pgen.1002913.g006
Reprogramming Permits Whole-Chromosome Instability
PLOS Genetics | www.plosgenetics.org 11 August 2012 | Volume 8 | Issue 8 | e1002913
Hybridoma Bank) for 1 h in PBS containing 0.1% Triton X-100
and 5% FCS. The cells were washed 36with PBS and incubated
with the appropriate AlexaFluor-conjugated secondary antibodies
(Invitrogen). After Hoechst staining, the cells were mounted in
Vectashield mounting medium (Vector Labs). For Top2a staining,
the cells were treated with 0.1 mM monastrol (Biomol, GR322-
0025) for 3 h before fixation and the staining was performed as
previously described [24]. Western blotting for RanBP2 and
BubR1 was performed as previously described [24,55]. Antibodies
from TopoGEN (#2010-1A) and Santa Cruz (SC-6243) were used
to detect Top2a and p53, respectively. The antibody against p16
was as previously described [25,27].
Chromosome Counting
iPSC clones (or subclones) growing on SNL feeders were
incubated for 4 h with 0.8 mg/ml KaryoMax Colcemid (Invitro-
gen). The cells were then harvested, incubated in 0.075 M KCl
solution for 12 min at 37uC and fixed in 3:1 methanol to acetic
acid (v/v) solution. After two washes with fixative, the iPSC
suspension was dropped onto glass slides and dried on wet paper
towels. The slides were stained with KaryoMAX Giemsa staining
solution (Invitrogen) according to the manufacture’s instructions.
Chromosome numbers of 50 or 100 metaphase spreads were
counted for each iPSC line.
Supporting Information
Figure S1 Analysis of cell cycle inhibition before and after
reprogramming. (A) Growth curves of P5 MEFs. Curves were
generated from three independent clones per genotype seeded in
duplicates. Error bars represent SD. (B) Western blot analysis of
wildtype and BubR1H/H iPSC extracts probed for p53 and p16.
Actin served as a loading control.
(TIF)
Figure S2 Potential models for selective reprogramming of
aneuploid BubR1H/H MEFs. We observed that .90% BubR1H/H
iPSC clones have a majority population consisting of a
chromosome number other than 40 even though only 38% of
MEFs were aneuploid at the onset of reprogramming. Two
possible mechanisms, designated A and B, might explain this
observation. According to mechanism A (highlighted in black
font), the chromosome number of the founding MEF cell at the
onset of reprogramming represents the chromosome number of
the majority population of the iPSC clone. This mechanism would
indicate a bias for reprogramming of karyotypically abnormal
BubR1H/H MEF cells. According to mechanism B (highlighted in
red font), the chromosome number of the founding MEF cell does
not represent the chromosome number of the majority population
of the iPSC clone due to a sharp increase in aneuploidization rates
when cells reach the reprogrammed state. This mechanism would
even be consistent with a bias against reprogramming of
karyotypically abnormal MEF cells. If mechanism B holds true,
one would expect to see no correlation between the spectrum of
chromosome losses and gains of a parental iPSC clone and its
single cell-derived subclones.
(TIF)
Figure S3 Measurement of the degree of RanBP2 insufficiency
in RanBP2–/H iPSC clones. (A) Western blot analysis of serially
diluted RanBP2+/+ iPSC cell lysates for RanBP2 and actin. (B) The
average RanBP2 signal intensity of 3 independent RanBP2+/+
iPSC clones plotted against percentage of lysate volume loaded
using the indicated equation. (C) Relative RanBP2 protein amount
in RanBP2–/H iPSC clones. Lysates from the indicated RanBP2–/H
iPSCs clones and from wildtype iPSC clones were subjected to
western blot against RanBP2 and actin. Using Image J, the
RanBP2 signal was calculated, normalized to background,
normalized to actin, and then averaged between duplicates. The
value for each RanBP2–/H iPSCs clone was then normalized to
wildtype. The relative RanBP2 protein amount (%) was then
calculated with the graph and equation in (B).
(TIF)
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